Meta Pixel

News and Announcements

Warburton Global Fund Dominates Bloomberg Global Hedge Fund Rankings

  • Published February 08, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

The Warburton Global Fund is an Australian based global macro hedge fund. It invests in listed equity, fixed income, currency and commodity markets worldwide.

Founded in 2015, Warburton Investment Management is recognised as one of the best performing firms in the hedge fund industry, with a mandate to target annualised returns of over 30%.

Based out of Perth, we have flown under the radar until quite recently.

Bloomberg’s recent 2017 hedge fund ranking report shows that the fund has outperformed the majority of its multi-billion dollar global peers over the last two years:

  • 2nd best performing hedge fund in Asia in 2017 (behind the Solitude Capital Master Fund)
  • 2nd best performing hedge fund in the World over the last two years (behind the Tribeca Global Natural Resources Fund)
  • 2nd most consistent hedge fund in the World over the last two years (behind Bluecrest)

About Warburton Investment Management

Warburton Investment Management manages client capital via the Warburton Global Fund, a global macro hedge fund that deals in international investments. The fund invests in public equity, fixed income, currency and commodity markets worldwide.

Founded in 2015, Warburton Investment Management is one of the best performing firms in the hedge fund industry, with a mandate to target annualised returns of over 30%.

Request Offer

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now